Wow! A 9.2% Dividend Yield with 32.85% in upside potential?

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [The Strategic Gold Play You Haven't Heard About]( [Get the full story on this overlooked gold investment strategy here.]( --------------------------------------------------------------- October 11, 2023 From the desk of the Editor Dear Reader, We have identified several stocks which are expected to go “Ex-Dividend” very soon. If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. So please keep this in mind. Below is our latest Dividend Report: --------------------------------------------------------------- Sponsor Message [The "Plug and Play" Model Putting Online Giants to Shame]( e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough." (THIS IS A PAID ADVERTISEMENT) [See How This Repeatable Model Keeps Growing While So Many Others are Shrinking]( --------------------------------------------------------------- [AbbVie]( Symbol: [ABBV]( Recent Price: $148.89 Average Analyst Price Target: $168.60 (13.84%) Market Cap: $261.65B Expected Ex-Dividend Date: Oct 12 2023 Expected Payment Date: Nov 15 2023 Expected Dividend & Yield: 3.92% Recent Analyst Action: Gary Nachman, analyst at Raymond James, reiterates coverage on [AbbVie (ABBV)]( in the Healthcare sector with a Buy rating and a price target of $177 (1 week ago). [TipRanks.com]( also reports that [AbbVie]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $168.60 . The target pricing ranges from a high forecast of $189 down to a low forecast of $147. [AbbVie (ABBV)](’s last closing price was $148.89 which would put the average price target at 13.84% upside. Here are 3rd party ratings for [ABBV](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 14% (217 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [$37 Trillion Building Targeted by China?]( China’s authoritarian government were to successfully attack this building, it could topple $37 trillion of the global economy, plummet the United States into a crippling depression and transform the United States into what the director of the FBI describes as a Cold War-era East Germany. It’s recommended that every American take a few moments to view [this interview.]( It features a decorated U.S. Air Force veteran who has advised the Pentagon, DARPA and NATO. He has teamed up with a leading economist to warn Americans of the dire threats each of us faces in the months ahead to our national and financial security. --------------------------------------------------------------- [Mid-America Apartment]( Symbol: [MAA]( Recent Price: $132.42 Average Analyst Price Target: $154.90 (21.30%) Market Cap: $15.21B Expected Ex-Dividend Date: Oct 12 2023 Expected Payment Date: Oct 31 2023 Expected Dividend & Yield: 4.08% Recent Analyst Action: Haendel St., analyst at Mizuho Securities, reiterates coverage on [Mid-America Apartment (MAA)]( in the Real Estate sector with a Hold rating and a price target of $133 (2 weeks ago). [TipRanks.com]( also reports that [Mid-America Apartment]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $154.90 . The target pricing ranges from a high forecast of $170 down to a low forecast of $133. [Mid-America Apartment (MAA)](’s last closing price was $132.42 which would put the average price target at 21.30% upside. Here are 3rd party ratings for [MAA](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 22% (55 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [WPP]( Symbol: [WPP]( Recent Price: $45.60 Average Analyst Price Target: $30.87 (-32.30%) Market Cap: $9.54B Expected Ex-Dividend Date: Oct 12 2023 Expected Payment Date: Nov 03 2023 Expected Dividend & Yield: 5.36% Recent Analyst Action: Adrien Hilaire, analyst at Bank of America Securities, reiterates coverage on [WPP (WPP)]( in the Communication Services sector with a Sell rating and a price target of $46 (2 weeks ago). [TipRanks.com]( also reports that [WPP]( currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $30.87 . The target pricing ranges from a high forecast of $46 down to a low forecast of $15.73. [WPP (WPP)](’s last closing price was $45.60 which would put the average price target at -32.30% upside. Here are 3rd party ratings for [WPP](: - TipRanks.com: Hold - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Bottom 4% (241 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Gold Could Be Heading for Record Highs - But How to Play It?]( to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. [See this little-known way to play in the rising gold market.]( --------------------------------------------------------------- [Foot Locker]( Symbol: [FL]( Recent Price: $21.05 Average Analyst Price Target: $21.75 (-4.04%) Market Cap: $1.86B Expected Ex-Dividend Date: Oct 12 2023 Expected Payment Date: Oct 27 2023 Expected Dividend & Yield: 7.72% Recent Analyst Action: Robert Drbul, analyst at Guggenheim, reiterates coverage on [Foot Locker (FL)]( in the Consumer Cyclical sector with a Buy rating and a price target of $23 (4 days ago). [TipRanks.com]( also reports that [Foot Locker]( currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $21.75 . The target pricing ranges from a high forecast of $27 down to a low forecast of $18. [Foot Locker (FL)](’s last closing price was $21.05 which would put the average price target at -4.04% upside. Here are 3rd party ratings for [FL](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Strong Sell, Bottom 34% (165 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [PennyMac Mortgage]( Symbol: [PMT]( Recent Price: $12.18 Average Analyst Price Target: $13.70 (14.29%) Market Cap: $1.03B Expected Ex-Dividend Date: Oct 12 2023 Expected Payment Date: Oct 27 2023 Expected Dividend & Yield: 13.81% Recent Analyst Action: Matthew Howlett, analyst at B.Riley Financial, reiterates coverage on [PennyMac Mortgage (PMT)]( in the Financial sector with a Buy rating and a price target of $15 (2 months ago). [TipRanks.com]( also reports that [PennyMac Mortgage]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $13.70 . The target pricing ranges from a high forecast of $15 down to a low forecast of $12.5. [PennyMac Mortgage (PMT)](’s last closing price was $12.18 which would put the average price target at 14.29% upside. Here are 3rd party ratings for [PMT](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Bottom 4% (240 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [My Gift to You]( I have arranged for you to receive [a complimentary 3-month subscription]( to Bernie Schaeffer’s Option Advisor online newsletter. [CLICK HERE]( for 3 Months FREE of Bernie Schaeffer’s Option Advisor ($395 Retail Value - [FREE!]() --------------------------------------------------------------- [Advance Auto Parts]( Symbol: [AAP]( Recent Price: $52.09 Average Analyst Price Target: $56.67 (32.85%) Market Cap: $3.09B Expected Ex-Dividend Date: Oct 12 2023 Expected Payment Date: Oct 27 2023 Expected Dividend & Yield: 9.25% Recent Analyst Action: Max Rakhlenko, analyst at TD Cowen, reiterates coverage on [Advance Auto Parts (AAP)]( in the Consumer Cyclical sector with a Hold rating and a price target of $55 (1 day ago). [TipRanks.com]( also reports that [Advance Auto Parts]( currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $56.67 . The target pricing ranges from a high forecast of $60 down to a low forecast of $55. [Advance Auto Parts (AAP)](’s last closing price was $52.09 which would put the average price target at 32.85% upside. Here are 3rd party ratings for [AAP](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Bottom 11% (224 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Abbott Labs]( Symbol: [ABT]( Recent Price: $97.56 Average Analyst Price Target: $122.00 (24.83%) Market Cap: $168.12B Expected Ex-Dividend Date: Oct 12 2023 Expected Payment Date: Nov 15 2023 Expected Dividend & Yield: 2.07% Recent Analyst Action: Matthew Taylor, analyst at Jefferies, reiterates coverage on [Abbott Labs (ABT)]( in the Healthcare sector with a Hold rating and a price target of $112 (1 week ago). [TipRanks.com]( also reports that [Abbott Labs]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $122.00 . The target pricing ranges from a high forecast of $131 down to a low forecast of $112. [Abbott Labs (ABT)](’s last closing price was $97.56 which would put the average price target at 24.83% upside. Here are 3rd party ratings for [ABT](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 42% (105 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Would Buffet Approve of This Growth Strategy?]( Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market. (THIS IS A PAID ADVERTISEMENT) [Find Out Why Investors are So Impressed by This New Spin On Value Investing]( --------------------------------------------------------------- And there you have it... Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information. Sincerely, The Editor, MarketSectorDaily.com MarketSectorDaily.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( This is part of your free subscription to MarketSectorDaily.com MarketSectorDaily.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Mt. Mourne | North Carolina | 28123 | United States | 8774119808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software